Available in Argentina, United States
This is a randomized, controlled study to evaluate the efficacy and safety of iptacopan
in combination with RTX induction therapy for the treatment of newly diagnosed or
relapsed patients with active GPA or MPA.
3Research sites
78Patients around the world